04:41 PM EST, 01/08/2025 (MT Newswires) -- Avadel Pharmaceuticals ( AVDL ) reported preliminary Q4 net product revenue Wednesday of $50 million, up from $19.5 million a year earlier.

Analysts polled by FactSet expect $52 million.

The company expects 2025 net product revenue of $240 million to $260 million. Analysts surveyed by FactSet expect $288.9 million.

Shares of the company plunged 23% in recent after-hours activity.

Price: 8.20, Change: -2.49, Percent Change: -23.29